next quarter could see more good news if results are positive
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial, page-5
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.8¢ |
Change
-0.028(3.07%) |
Mkt cap ! $1.064B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 88.5¢ | 85.8¢ | $2.022M | 2.333M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 22962 | 86.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 22245 | 18 |
View Market Depth
| Last trade - 14.05pm 08/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |